PHATHOM PHARMACEUTICALS
Phathom Pharmaceuticals, launched in 2019 by Frazier Healthcare Partners and Takeda Pharmaceuticals, is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal (GI) diseases and disorders. The company is advancing the clinical drug candidate vonoprazan, a novel potassium-competitive acid blocker (P-CAB). Vonoprazan has the potential to address multiple unmet needs among patients with gastroesophageal reflux disease (GERD) and other acid-related disorders. Phathom has assembled a leading team of seasoned gastrointestinal and pharmaceutical industry experts with proven experience developing and commercializing highly innovative therapies.
PHATHOM PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Pharmaceutical
Founded:
2018-01-01
Address:
Florham Park, New Jersey, United States
Country:
United States
Website Url:
http://www.phathompharma.com
Total Employee:
11+
Status:
Active
Contact:
(650) 325-5156
Email Addresses:
[email protected]
Total Funding:
340 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Global Site Tag Mobile Non Scaleable Content Sitelinks Search Box
Similar Organizations
Accent Therapeutics
Accent Therapeutics is a biopharmaceutical company.
Amryt Pharma
Amryt Pharma creates and delivers innovative treatments to help patients with rare and orphan diseases live better lives.
Arkuda Therapeutics
Arkuda Therapeutics is a pharmaceutical company.
Cerevel Therapeutics
Cerevel Therapeutics is a biopharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Corvus Pharmaceuticals
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.
Nuvation Bio
Nuvation Bio is a biopharmaceutical company.
Nymox Pharmaceutical
Nymox Pharmaceutical is a biopharmaceutical company.
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
ORIC Pharmaceuticals
ORIC Pharmaceuticals operates as a biopharmaceutical company.
Osmotica Pharmaceutical
Osmotica Pharmaceutical is a global specialty pharmaceutical company.
SciClone Pharmaceuticals
SciClone Pharmaceuticals is a pharmaceutical company.
Thetis Pharmaceuticals
Thetis Pharmaceuticals is a biopharmaceutical company.
Zhaoke Ophthalmology Pharmaceutical
Zhaoke Ophthalmology Pharmaceutical is a Pharmaceutical platform.
Zomedica
Zomedica is a veterinary pharmaceutical company.
Current Employees Featured
Founder
Stock Details
Investors List
Hercules Capital
Hercules Capital investment in Post-IPO Debt - Phathom Pharmaceuticals
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Private Equity Round - Phathom Pharmaceuticals
Silicon Valley Bank
Silicon Valley Bank investment in Debt Financing - Phathom Pharmaceuticals
Abingworth
Abingworth investment in Private Equity Round - Phathom Pharmaceuticals
Catalys Pacific
Catalys Pacific investment in Private Equity Round - Phathom Pharmaceuticals
Janus Henderson Investors
Janus Henderson Investors investment in Private Equity Round - Phathom Pharmaceuticals
Medicxi
Medicxi investment in Private Equity Round - Phathom Pharmaceuticals
RA Capital Management
RA Capital Management investment in Private Equity Round - Phathom Pharmaceuticals
Greenspring Associates
Greenspring Associates investment in Private Equity Round - Phathom Pharmaceuticals
Biotechnology Value Fund
Biotechnology Value Fund investment in Private Equity Round - Phathom Pharmaceuticals
Key Employee Changes
| Date | New article |
|---|---|
| 2022-03-22 | Phathom Pharmaceuticals Announces Appointment of Molly Henderson as Chief Financial and Business Officer |
| 2020-01-06 | Phathom Pharmaceuticals names chief commercial officer |
Official Site Inspections
http://www.phathompharma.com Semrush global rank: 4.13 M Semrush visits lastest month: 2.9 K
- Host name: 95.70.73.34.bc.googleusercontent.com
- IP address: 34.73.70.95
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Phathom Pharmaceuticals"
About Us - Phathom Pharmaceuticals
Paul Cocja is the former Vice President, People and Organization for Novartis’ U.S. Pharmaceutical Division and most recently led their U.S. Transformation Office. He has over 35 years of Human Resources (HR) experience, the …See details»
Phathom Pharmaceuticals Announces Leadership Succession
2 days ago FLORHAM PARK, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing …See details»
Investors & Media | Phathom Pharmaceuticals, Inc.
Jan 29, 2025 Management to host conference call on Thursday, March 6, 2025, at 8:30 am ET FLORHAM PARK, N.J., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, …See details»
Life at Phathom - Phathom Pharmaceuticals
At Phathom, we consider each other as “Phamily.” We are a team of highly driven pharmaceutical professionals who are passionate about our mission to improve the lives of people suffering …See details»
Phathom Pharmaceuticals Announces Leadership Succession
2 days ago FLORHAM PARK, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing...See details»
Phathom Pharmaceuticals - Crunchbase Company …
Contact Email [email protected] Phone Number (650) 325-5156 Phathom Pharmaceuticals, launched in 2019 by Frazier Healthcare Partners and Takeda Pharmaceuticals, is a biopharmaceutical company focused on the …See details»
Phathom Pharmaceuticals | The Healthcare Technology Report.
Visit Phathompharma.com ... Collaboration is highly valued, both within the organization and with external partners, to leverage expertise and achieve shared goals. The company promotes a …See details»
Phathom Pharmaceuticals - Craft
Oct 28, 2024 Phathom Pharmaceuticals is a biopharmaceutical company focused on treating gastrointestinal diseases and disorders. The company offers Vonoprazan, a small molecule …See details»
Phathom Pharmaceuticals Company Overview, Contact Details
Aug 19, 2024 Phathom attended event Guggenheim Securities SMID Cap Biotech Conference on Feb 6th '25. FLORHAM PARK, N.J., Jan. 29, 2025 (GLOBE NEWSWIRE) - Phathom …See details»
Overview, News & Similar companies - ZoomInfo.com
Oct 18, 2024 Phathom Pharmaceuticals is a late clinical-stage biopharmaceutical company focused on developing and commercializing new treatments for GI disorder s. We have …See details»
Phathom Pharmaceuticals Announces Leadership Succession
3 days ago FLORHAM PARK, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing …See details»
Phathom Pharmaceuticals Inc: Overview - GlobalData
Website www.phathompharma.com Telephone 1 302 6365400. No of Employees 452. Industry Pharmaceuticals and Healthcare. Ticker Symbol & Exchange PHAT (NASD) Revenue (2023) …See details»
Phathom Pharmaceuticals Company Profile | Management and
SQL International Organization for Standardization . HTML Web Hypertext Application Technology Working Group . CSS World Wide Web Consortium . PHP PHP . Web Analytics ...See details»
Phathom Pharmaceuticals to Participate in Upcoming Investor …
FLORHAM PARK, N.J., May 28, 2024 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing …See details»
Phathom Pharmaceuticals Announces Leadership Succession
2 days ago FLORHAM PARK, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing …See details»
Phathom Pharmaceuticals to Report Fourth Quarter and Full Year …
Feb 24, 2025 Management to host conference call on Thursday, March 6, 2025, at 8:30 am ET; FLORHAM PARK, N.J., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, …See details»
Overview, News & Similar companies - ZoomInfo.com
May 27, 2024 Who is Phathom Pharmaceuticals. Phathom Pharmaceuticals is a late clinical-stage biopharmaceutical company focused on developing and commercializing new …See details»
Medical Information - Phathom Pharmaceuticals
Learn about the acid-related disease landscape we are committed to evolving, including our robust clinical programs and late-stage research.See details»
Phathom Pharmaceuticals to Participate in Upcoming Investor …
FLORHAM PARK, N.J., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing …See details»
News Release - investors.phathompharma.com
15 hours ago FLORHAM PARK, N.J., April 03, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing …See details»